These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15870591)

  • 21. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined behavioral and pharmacological treatment of essential hypertension.
    Hatch JP; Klatt KD; Supik JD; Rios N; Fisher JG; Bauer RL; Shimotsu GW
    Biofeedback Self Regul; 1985 Jun; 10(2):119-38. PubMed ID: 3914313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biofeedback assisted relaxation in essential hypertension: short-term follow-up of contributing effects of pharmacotherapy on blood pressure and heart rate. "Brief communication".
    Cengiz E; Unalan H; Tuğrul A; Ekerbiçer H
    Yonsei Med J; 1997 Apr; 38(2):86-90. PubMed ID: 9175485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aortic Stiffness, Ambulatory Blood Pressure, and Predictors of Response to Antihypertensive Therapy in Hemodialysis.
    Georgianos PI; Agarwal R
    Am J Kidney Dis; 2015 Aug; 66(2):305-12. PubMed ID: 25818679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relaxation therapy with respiratory feedback in patients with essential hypertension].
    Franck M; Schäfer H; Stiels W; Wassermann R; Herrmann JM
    Psychother Psychosom Med Psychol; 1994; 44(9-10):316-22. PubMed ID: 7972649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-invasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients: effects on home blood pressure in the BEAUTY study.
    Talvik A; Rebora P; Heinpalu-Kuum M; Salerno S; Miszkowska-Nagórna E; Liu X; Comotti T; Świerblewska E; Valsecchi MG; Fadl Elmula FEM; Larstorp AC; Narkiewicz K; Parati G; Laurent S; Viigimaa M;
    Blood Press; 2018 Dec; 27(6):368-375. PubMed ID: 30129785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoring sinus rhythm results in blood pressure reduction in patients with persistent atrial fibrillation and a history of hypertension.
    Sanders NA; Bertolone C; Jetter TL; Wasmund SL; Croci F; Solano A; Brignole M; Hamdan MH
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):722-6. PubMed ID: 22494504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can blood pressure responses to tests unmask future blood pressure trends and the need for antihypertensive medication? Ten years of follow-up.
    Jokiniitty J; Majahalme S; Kähönen M; Tuomisto MT; Turjanmaa V
    Clin Physiol Funct Imaging; 2002 Mar; 22(2):125-33. PubMed ID: 12005154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relaxation therapy for hypertension: setting-specific effects.
    Jacob RG; Shapiro AP; O'Hara P; Portser S; Kruger A; Gatsonis C; Ding Y
    Psychosom Med; 1992; 54(1):87-101. PubMed ID: 1553404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of a pill box clinic to improve systolic blood pressure in veterans with uncontrolled hypertension taking 3 or more antihypertensive medications.
    Porter AK; Taylor SR; Yabut AH; Al-Achi A
    J Manag Care Spec Pharm; 2014 Sep; 20(9):905-11. PubMed ID: 25166289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Successful Multifaceted Trial to Improve Hypertension Control in Primary Care: Why Did it Work?
    Margolis KL; Asche SE; Bergdall AR; Dehmer SP; Maciosek MV; Nyboer RA; O'Connor PJ; Pawloski PA; Sperl-Hillen JM; Trower NK; Tucker AD; Green BB
    J Gen Intern Med; 2015 Nov; 30(11):1665-72. PubMed ID: 25952653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of group relaxation training and thermal biofeedback on blood pressure and related physiological and psychological variables in essential hypertension.
    McGrady A
    Biofeedback Self Regul; 1994 Mar; 19(1):51-66. PubMed ID: 8167164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of an olmesartan medoxomil-based treatment algorithm in patients with hypertension and type 2 diabetes: analysis of diurnal blood pressure control as assessed by 24-hour ambulatory blood pressure monitoring.
    Kereiakes DJ; Neutel J
    Ther Adv Cardiovasc Dis; 2010 Oct; 4(5):285-93. PubMed ID: 20801941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential follow-up clinic and ambulatory blood pressure evaluation in a low risk population of white-coat hypertensive patients and in normotensives.
    Polónia JJ; Gama GM; Silva JA; Amaral C; Martins LR; Bertoquini SE
    Blood Press Monit; 2005 Apr; 10(2):57-64. PubMed ID: 15812251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of response to biofeedback-assisted relaxation in hypertensives: development of a Hypertensive Predictor Profile (HYPP).
    McGrady A; Higgins JT
    Psychosom Med; 1989; 51(3):277-84. PubMed ID: 2660184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Voluntary blood pressure control using continuous systolic blood pressure biofeedback.
    Cejnar M; Hunyor SN; Liggins GW; Bartrop R
    Clin Exp Pharmacol Physiol; 1988 Apr; 15(4):265-9. PubMed ID: 3271609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.